Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TLR7 and TLR8 as targets in cancer therapy
Michael P. Schön, Michael P. Schön
Oncogene (2008) Vol. 27, Iss. 2, pp. 190-199
Closed Access | Times Cited: 283

Showing 1-25 of 283 citing articles:

Differential macrophage programming in the tumor microenvironment
Brian Ruffell, Nesrine I. Affara, Lisa M. Coussens
Trends in Immunology (2012) Vol. 33, Iss. 3, pp. 119-126
Open Access | Times Cited: 807
Interstitial leukocyte migration and immune function
Peter Friedl, Bettina Weigelin
Nature Immunology (2008) Vol. 9, Iss. 9, pp. 960-969
Closed Access | Times Cited: 550
Toll-like receptor signaling in neural plasticity and disease
Eitan Okun, Kathleen J. Griffioen, Mark P. Mattson
Trends in Neurosciences (2011) Vol. 34, Iss. 5, pp. 269-281
Open Access | Times Cited: 484
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
Luke O'neill, Clare Bryant, Sarah Doyle
Pharmacological Reviews (2009) Vol. 61, Iss. 2, pp. 177-197
Open Access | Times Cited: 411
The Yin and Yang of Toll-like receptors in cancer
Jean‐Philippe Pradère, Dianne H. Dapito, Robert F. Schwabe
Oncogene (2013) Vol. 33, Iss. 27, pp. 3485-3495
Open Access | Times Cited: 305
Toll-Like Receptor Agonists in Cancer Therapy
Sylvia Adams
Immunotherapy (2009) Vol. 1, Iss. 6, pp. 949-964
Open Access | Times Cited: 282
Anti‐tumour strategies aiming to target tumour‐associated macrophages
Xiaoqiang Tang, Chunfen Mo, Yongsheng Wang, et al.
Immunology (2012) Vol. 138, Iss. 2, pp. 93-104
Open Access | Times Cited: 252
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
Baharak Bahmani, Hua Gong, Brian T. Luk, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 217
Promoter G-quadruplexes and transcription factors cooperate to shape the cell type-specific transcriptome
Sara Lago, Matteo Nadai, Filippo M. Cernilogar, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 190
Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy
Yuanyuan Liu, Linan Qiao, Sipei Zhang, et al.
Acta Biomaterialia (2017) Vol. 66, pp. 310-324
Closed Access | Times Cited: 186
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Katherine A. Michaelis, Mason A. Norgard, Xinxia Zhu, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 172
TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection
Marine de Marcken, Khushwant Dhaliwal, Ann Caroline Danielsen, et al.
Science Signaling (2019) Vol. 12, Iss. 605
Open Access | Times Cited: 158
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
Sachin Bhagchandani, Jeremiah A. Johnson, Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113803-113803
Open Access | Times Cited: 124
Engineered nanomaterials for synergistic photo-immunotherapy
Ranran Guo, Siqi Wang, Lin Zhao, et al.
Biomaterials (2022) Vol. 282, pp. 121425-121425
Closed Access | Times Cited: 106
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 75
The role of Toll-like receptors in chronic inflammation
Stefan K. Drexler, Brian M. J. Foxwell
The International Journal of Biochemistry & Cell Biology (2009) Vol. 42, Iss. 4, pp. 506-518
Closed Access | Times Cited: 238
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
Julien Cherfils‐Vicini, Sophia Platonova, Mélanie Gillard, et al.
Journal of Clinical Investigation (2010) Vol. 120, Iss. 4, pp. 1285-1297
Open Access | Times Cited: 216
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
Sylvia Adams, Lina Kozhaya, Frank Martiniuk, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 24, pp. 6748-6757
Open Access | Times Cited: 206
Tumor immunosurveillance in human cancers
Bernhard Mlecnik, Gabriela Bindea, Franck Pagès, et al.
Cancer and Metastasis Reviews (2011) Vol. 30, Iss. 1, pp. 5-12
Open Access | Times Cited: 205
The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
Evelien Smits, Peter Ponsaerts, Zwi Berneman, et al.
The Oncologist (2008) Vol. 13, Iss. 8, pp. 859-875
Open Access | Times Cited: 205
Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
Shaherin Basith, Balachandran Manavalan, Tae Hyeon Yoo, et al.
Archives of Pharmacal Research (2012) Vol. 35, Iss. 8, pp. 1297-1316
Closed Access | Times Cited: 197
Surface RANKL of Toll-like receptor 4–stimulated human neutrophils activates osteoclastic bone resorption
Arpita Chakravarti, Marie-Astrid Raquil, Philippe A. Tessier, et al.
Blood (2009) Vol. 114, Iss. 8, pp. 1633-1644
Open Access | Times Cited: 193
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
Abbi L. Engel, Gregory E. Holt, Hailing Lu
Expert Review of Clinical Pharmacology (2011) Vol. 4, Iss. 2, pp. 275-289
Open Access | Times Cited: 180
Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms
Stéphanie Demoulin, Michaël Herfs, Philippe Delvenne, et al.
Journal of Leukocyte Biology (2012) Vol. 93, Iss. 3, pp. 343-352
Closed Access | Times Cited: 146
Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
Md. Zahidunnabi Dewan, Claire Vanpouille‐Box, Noriko Kawashima, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 24, pp. 6668-6678
Open Access | Times Cited: 146
Page 1 - Next Page

Scroll to top